search button

Verteporfin enhances the sensitivity of LOVO/TAX cells to taxol via YAP inhibition

  • Authors:
    • Ganggang Shi
    • Hao Wang
    • Hongqiu Han
    • Jianchen Gan
    • Hui Wang

  • View Affiliations

  • Published online on: July 16, 2018     https://doi.org/10.3892/etm.2018.6447
  • Pages: 2751-2755
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Studies have reported that taxol (TAX) is an effective drug for the treatment of colorectal cancer; however, its application inevitably results in drug resistance. Overexpression of Yes‑associated protein (YAP) is considered one of the factors that cause TAX resistance, which may be inhibited by verteporfin (VP) treatment. The present study aimed to confirm the role of YAP in TAX resistance and to investigate whether the drug sensitivity of the TAX‑resistant LOVO/TAX cell line to TAX is affected by VP treatment. The role of YAP in TAX resistance was first determined through vector‑mediated overexpression and inhibition of YAP in cells. Reverse‑transcription quantitative polymerase chain reaction and western blot analysis were performed for detection of associated mRNA and protein, respectively. An MTT assay was used to detect the drug sensitivity of cells to TAX. The results suggested that compared with that in the native LOVO cell line, YAP expression was significantly increased in LOVO/TAX cells. YAP gene silencing markedly enhanced the drug sensitivity of LOVO/TAX cells to TAX and, on the contrary, the drug sensitivity notably declined when YAP was overexpressed in LOVO cells. The results indicated that YAP gene expression and TAX resistance were correlated. VP treatment suppressed YAP expression and increased the drug sensitivity of LOVO/TAX cells to TAX in a dose‑dependent manner. In addition, compared with VP alone, VP and TAX combination therapy had a greater inhibitory effect on YAP expression. VP treatment enhanced the drug sensitivity of LOVO/TAX cells to TAX through inhibiting YAP expression.
View Figures
View References

Related Articles

Journal Cover

September-2018
Volume 16 Issue 3

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.7
  • Ranked Medicine Research and Experimental
    (total number of cites)
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Shi G, Wang H, Han H, Gan J and Wang H: Verteporfin enhances the sensitivity of LOVO/TAX cells to taxol via YAP inhibition. Exp Ther Med 16: 2751-2755, 2018
APA
Shi, G., Wang, H., Han, H., Gan, J., & Wang, H. (2018). Verteporfin enhances the sensitivity of LOVO/TAX cells to taxol via YAP inhibition. Experimental and Therapeutic Medicine, 16, 2751-2755. https://doi.org/10.3892/etm.2018.6447
MLA
Shi, G., Wang, H., Han, H., Gan, J., Wang, H."Verteporfin enhances the sensitivity of LOVO/TAX cells to taxol via YAP inhibition". Experimental and Therapeutic Medicine 16.3 (2018): 2751-2755.
Chicago
Shi, G., Wang, H., Han, H., Gan, J., Wang, H."Verteporfin enhances the sensitivity of LOVO/TAX cells to taxol via YAP inhibition". Experimental and Therapeutic Medicine 16, no. 3 (2018): 2751-2755. https://doi.org/10.3892/etm.2018.6447